Faslomax 250 Mg Injection

Product Description

Product details

• Packing  : 1*1
• Country of Origin  : Made in India
• Strength  : 250mg
• Storage  : 250mg
• Form  : Injection
• Prescription/Non prescription  : Prescription
• Treatment  : breast cancer cells
• Composition  : Fulvestrant (250mg)
• Brand  : Faslomax 

Precise Hormonal Therapy for Breast Cancer

Faslomax 250 Mg Injection delivers targeted antiestrogen therapy for adult women with hormone receptor-positive, advanced, or metastatic breast cancer. By blocking estrogen activity, Fulvestrant helps manage tumor growth when other hormone therapies may not be effective. Its high purity and ready-to-use formulation ensure a standardized and dependable dosing experience.


Administration and Safety Measures

Administered exclusively through intramuscular injection, Faslomax must be given by a healthcare professional in a clinical setting. Special attention is warranted in patients with liver impairment, and injection site reactions should be closely monitored. The medication is contraindicated in pregnancy, lactation, and those with hypersensitivity to Fulvestrant, emphasizing the importance of thorough pre-administration assessment.


Storage and Handling Guidelines

To maintain its efficacy, Faslomax should be stored below 25C and must not be frozen. The medication comes in a clear, single-use vial for one-time dosing, ensuring both safety and sterility. With a shelf life of up to 24 months, it is well-suited for oncology departments and clinical facilities who require reliable hormone antagonist therapies.